A Study of AT-02 in Subjects With Systemic Amyloidosis.

NCT05951049 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyloidosis; Systemic

Interventions

DRUG: AT02

Sponsor

Attralus, Inc.

Collaborators

[object Object]